MarketInOut Stock Screener Log In | Sign Up

Quest PharmaTech Inc

TSXV • Healthcare • Biotechnology • Quote as of 10/29/2026
Quest PharmaTech Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeTSXV
Market Capitalization3.38 mln
Float139 mln
Earnings Date12/21/2026

EPS

0.03
Marginal

P / E

0.67
Anomalous

Piotroski F-Score

4 / 9
Borderline

Relative Strength

14 / 100
Significantly lagging

Debt / Equity

0.04
Debt-free

ROE

9.95
Low

Business Description

Quest PharmaTech is a Canadian company based in Edmonton, Alberta, focused on finding better ways to treat cancer. Its most advanced project involves a drug called MAb AR9.6, which is being studied as a potential treatment and diagnostic tool for pancreatic cancer. The drug is currently in early-stage laboratory testing.

Key Fundamentals

EPS0.03
P/E0.67
ROE9.95
ROIC-2.84
ROA9.45
EBITDA, mln2.31
EV / EBITDA1.89
EV / EBIT1.89

Quote Details

Last 0.02
Change 0 (0%)
Open 0.02
Volume 2,000
Turnover 40
Average Volume 25,609

Financial Ratios

Current Ratio0.03
Price / Book0.13
Price / Tangible Book0.13
Debt / Equity0.04

Financial Strength

Piotroski F-Score 4 / 9
Price to Intrinsic Value0.20
Price to Graham Number0.08
Shiller PE Ratio0.40
Short Ratio0.03

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -20% 7 / 100   
1 Month -20% 37 / 100   
2 Months -33.33% 21 / 100   
6 Months -50% 15 / 100   
1 Year -33.33% 33 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog